You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)組建基金 投資非腫瘤治療領域等
阿思達克 11-25 09:30
復星醫藥(02196.HK)公布,昨日(24日),附屬「寧波復瀛」和附屬合夥企業「復耀瀛創」分別出資1.65億元人民幣(下同)和500萬元,以與其他合夥人設立安吉投資基金,兩者佔安吉投資基金權益各33%和1%。另外,寧波復瀛和復耀瀛創以同等出資額及權益比例,以與其他合夥人設立徐州投資基金。 兩個基金募集資金均為5億元,公司及公司控股股東復星高科技持有60%及40%股權的復健基金應將委託作為安吉投資基金及徐州投資基金的基金管理人,期限自明年1月1日起計3年。 投資基金設立後,將定向投資非腫瘤治療領域,如自身免疫系統疾病、中樞神經系統疾病及代謝疾病,及腫瘤治療領域自研或引入的早期創新藥項目。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account